Approaches to vaccination against coronavirus infection in patients with autoimmune inflammatory rheumatic diseases
Infectious Diseases: News, Opinions, Training
; 11(4):118-126, 2022.
Article
in Russian
| EMBASE | ID: covidwho-2326600
ABSTRACT
The problem of COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases is discussed. There is an increased risk of viral infections in these patients. Attending physicians should provide patients with rheumatic diseases with complete information about the risks and benefits of COVID-19 immunoprophylaxis. The use of immunosuppressive drugs, rather than the diseases themselves, can reduce the level of post-vaccination immune response. This requires choosing the optimal time for carrying out COVID-19 vaccination in this group of patients. Fragments of European and American recommendations on vaccination against COVID-19 in patients with rheumatic diseases are given.Copyright © 2022 Infectious Diseases News, Opinions, Training.
autoimmune inflammatory rheumatic diseases; covid-19; immunosuppressants; vaccination; article; coronavirus disease 2019/dt [Drug Therapy]; coronavirus disease 2019/pc [Prevention]; human; immune response; immunoprophylaxis; infection risk; priority journal; rheumatic disease; SARS-CoV-2 vaccine/dt [Drug Therapy]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Topics:
Vaccines
Language:
Russian
Journal:
Infectious Diseases: News, Opinions, Training
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS